Florida Pharmacy CE Requirement 20-Hour Package
Included Courses
Courses included in this package. Click on a course to learn more.
- Addiction Medicine Part 2: Alcohol 2Course Release Date: 10/21/22
Alcohol use disorder is a serious national health problem in the United States. It is estimated that more than 14 million American adults had an alcohol use disorder in 2019, as well as 414,000 adolescents aged 12 to 17. There is a clear need for improvement in the treatment of alcohol use disorder; this course serves to review the recognition, diagnosis, and treatment of alcohol use disorder and alcohol withdrawal.
- Addiction Medicine: Part 1: Opioids and Other Scheduled Drug Classes 2Release Date: 4/27/22
About the Course
Addiction is a brain disorder that creates a large burden on both patients and society as a whole. Pharmacists play an important role in identifying and managing patients who are at risk of abusing or addicted to opioids, stimulants, and/or benzodiazepines. Medications can assist in quitting the use of certain substances, and pharmacists are in a key position to recommend appropriate therapy based on patient factors and comorbidities. Many patients will require more than one attempt at quitting, and pharmacy professionals can offer motivation and support during this difficult time. This course will offer insight into the impact of substance use disorders in the United States and help pharmacists identify patients suffering from these diseases. After completing this course, pharmacists will have an understanding of the available treatments for addiction to opioids, stimulants, and benzodiazepines.“This course will [partially] fulfill the DEA-mandated 8 hours of training on the treatment and management of patients with opioid or other substance use disorders for DEA licensees renewing on or after June 27, 2023.” - Educating Patients: Creating Teaching Moments in Practice 4Course release date: 12/21/2022
About the Course
Effective education is essential to help patients and family gain knowledge. All healthcare professionals (HCPs) can identify teaching opportunities to assess and provide effective education. The purpose of this course is to provide HCPs with current evidence-based information to help them learn and apply skills and practice for effective patient and family teaching in a variety of settings. - Management Of Drug Challenges: Generic vs Branded Drugs, 2nd Edition 1Course release date: 10/31/2022
About the Course
Written program is designed to help healthcare professionals best understand the generic drug environment, recognize when substitution is warranted, and work with their patients to fully understand and appreciate the process.
- Patient Safety and Medication Errors for Pharmacy Professionals 2
Course Release: 4/1/2024
About the course
This educational program is designed to accomplish at least two important goals: first to provide examples of critical potential medication errors, and secondly to offer mechanisms that pharmacy professionals can take to intervene in these mishaps and enhance patient care. In addition to offering these critical examples and potential solutions, two case studies are included to help put some of the ideas into realistic scenarios similar to those that may be encountered in contemporary pharmacy practice. Evidence-based practice information from current peer-reviewed literature is also included for context and ideas for pharmacists to consider in efforts to improve their practice appear throughout the program. Lastly, a post-test is included at the end of the program to test your understanding of the material.
- Updates in Sterile and Nonsterile Compounding Standards 3
Course Release: 4/3/2024
About the course
This intermediate-level course is intended for healthcare professionals interested in or have a role in compounding. The activity will review key changes in the current sterile and nonsterile compounding standards, set forth by the United States Pharmacopeia that went into effect on November 1, 2023.
- The Pharmacist's Role in the Opioid Crisis, 2nd Edition 6
Course Release: 1/9/2024
About the course
This course will provide pharmacists practicing in healthcare systems and community pharmacy settings an overview of contemporary considerations for ways that the opioid crisis intersects with pharmacy practice. This course will provide pharmacists with a history of the current state of the opioid crisis and how pharmacy practice has expanded to meet patient and community needs as well as ethical dimensions of the opioid crisis and the role of social determinants of health in opioid-related disparities. This course will provide pharmacists with an understanding of the disease state of opioid use disorder and how opioids affect the brain, how the pharmacist can be supportive of patients with opioid use disorder to reduce stigma and facilitate treatment-seeking, and the benefits of medications for opioid use disorder; participants will review the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain (2022 Clinical Practice Guideline).